Seoul Pharma Co. Ltd (018680) — Cash Flow Quality Index
Seoul Pharma Co. Ltd (018680) has a Cash Flow Quality Index of -1.01x as of September 2025. Operating cash flow of ₩-2.66 Billion is below net income of ₩2.62 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Seoul Pharma Co. Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Seoul Pharma Co. Ltd Cash Flow Quality Index (2008–2024)
Historical Cash Flow Quality Index for Seoul Pharma Co. Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Seoul Pharma Co. Ltd.
Annual Cash Flow Quality Index for Seoul Pharma Co. Ltd (2008–2024)
Year-by-year earnings quality comparison for Seoul Pharma Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.77x | ₩-3.01 Billion | ₩1.70 Billion | ▼ -218.3% |
| 2023 | 1.50x | ₩5.26 Billion | ₩3.52 Billion | ▲ +1736.4% |
| 2022 | -0.09x | ₩-78.21 Million | ₩855.09 Million | ▼ -100.7% |
| 2019 | 12.40x | ₩2.93 Billion | ₩236.21 Million | ▲ +1060.9% |
| 2017 | -1.29x | ₩-1.14 Billion | ₩881.45 Million | ▲ +44.2% |
| 2016 | -2.31x | ₩-1.89 Billion | ₩816.80 Million | ▼ -236.5% |
| 2013 | -0.69x | ₩-425.00 Million | ₩618.00 Million | ▼ -138.1% |
| 2012 | 1.81x | ₩9.22 Billion | ₩5.10 Billion | ▼ -50.4% |
| 2011 | 3.64x | ₩4.86 Billion | ₩1.33 Billion | ▲ +248.5% |
| 2009 | 1.05x | ₩1.23 Billion | ₩1.18 Billion | ▲ +175.0% |
| 2008 | -1.39x | ₩-755.68 Million | ₩542.04 Million | — |